Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intestinal expression of P-glycoprotein (ABCB1), multidrug resistance associated protein 2 (ABCC2), and uridine diphosphate-glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetimibe in humans.
Oswald S, Haenisch S, Fricke C, Sudhop T, Remmler C, Giessmann T, Jedlitschky G, Adam U, Dazert E, Warzok R, Wacke W, Cascorbi I, Kroemer HK, Weitschies W, von Bergmann K, Siegmund W. Oswald S, et al. Among authors: von bergmann k. Clin Pharmacol Ther. 2006 Mar;79(3):206-17. doi: 10.1016/j.clpt.2005.11.004. Epub 2006 Feb 7. Clin Pharmacol Ther. 2006. PMID: 16513445
Inhibition of intestinal cholesterol absorption by ezetimibe in humans.
Sudhop T, Lütjohann D, Kodal A, Igel M, Tribble DL, Shah S, Perevozskaya I, von Bergmann K. Sudhop T, et al. Among authors: von bergmann k. Circulation. 2002 Oct 8;106(15):1943-8. doi: 10.1161/01.cir.0000034044.95911.dc. Circulation. 2002. PMID: 12370217 Clinical Trial.
The lipid-lowering effect of ezetimibe in pure vegetarians.
Clarenbach JJ, Reber M, Lütjohann D, von Bergmann K, Sudhop T. Clarenbach JJ, et al. Among authors: von bergmann k. J Lipid Res. 2006 Dec;47(12):2820-4. doi: 10.1194/jlr.P600009-JLR200. Epub 2006 Sep 11. J Lipid Res. 2006. PMID: 16966491 Free article. Clinical Trial.
Lifibrol as a model compound for a novel lipid-lowering mechanism of action.
Berthold HK, Sudhop T, von Bergmann K, Gouni-Berthold I. Berthold HK, et al. Among authors: von bergmann k. J Cardiovasc Pharmacol Ther. 2010 Dec;15(4):364-72. doi: 10.1177/1074248410371100. Epub 2010 Aug 6. J Cardiovasc Pharmacol Ther. 2010. PMID: 20693157 Clinical Trial.
236 results